Markes International Opens New Chinese subsidiary in Shanghai
Markes International has announced the opening of a new subsidiary in Shanghai, China.
Markes International has announced the opening of a new subsidiary in Shanghai, China. The new Markes Instruments (Shanghai) Co., Ltd. operation will support Markes’s existing network of Chinese distributors and sales agents, and will be led by the recently appointed General Manager, Lili Tang.
Speaking about Markes’s new operation in China, Managing Director Tim Hawkins highlighted Markes’s impact across 60 countries, saying: “We are now building a new team of specialists to support our long-established partners in China, alongside investment in monitoring technologies focused on Chinese requirements.”
“Lili shares our drive for excellence and our passion for engaging with our partners to deliver the best results for our customers, and her appointment comes at a truly exciting time in Markes’s growth story,” said Hawkins.
Tang was previously the Director of Jiangsu Environmental Monitoring Centre and Professor in Nanjing University of Science and Technology, where she led province-wide atmospheric monitoring networks and established systems for air and ozone quality management. She joins Markes during a period of significant growth in the environmental monitoring market in China, and will be establishing Markes’s new Technology Support Centre in Shanghai along with an online portal.
For more information please visit www.markes.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
